Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Cirrhosis

  Free Subscription


3 Dig Dis
5 Gastroenterology
31 Hepatology
2 J Gastroenterol
1 Lancet Glob Health
3 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Dig Dis

  1. HUANG XW, Liao B, Huang Y, Liang JY, et al
    Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?
    Dig Dis. 2018 Jan 19. pii: 000486196. doi: 10.1159/000486196.
    PubMed     Text format     Abstract available

  2. KOBAYASHI N, Kumada T, Toyoda H, Tada T, et al
    Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.
    Dig Dis. 2017;35:521-530.
    PubMed     Text format     Abstract available

  3. YADA N, Tamaki N, Koizumi Y, Hirooka M, et al
    Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease.
    Dig Dis. 2017;35:515-520.
    PubMed     Text format     Abstract available


  4. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    PubMed     Text format    

  5. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    PubMed     Text format    

  6. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    PubMed     Text format    

  7. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    PubMed     Text format    

  8. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Text format     Abstract available


    Patient understanding of hepatocellular carcinoma surveillance.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29103.
    PubMed     Text format    

  10. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    

  11. GIANNINI EG, Savarino V
    Noninvasive assessment of varices needing treatment in patients with advanced chronic liver disease: No one should be left behind.
    Hepatology. 2017;65:2131.
    PubMed     Text format    

  12. LACKNER C, Bataller R, Burt A, Miquel R, et al
    Fibrosis evaluation by transient elastography in alcoholic liver disease: Is the histological scoring system impacting cutoff values?
    Hepatology. 2017;65:1758-1761.
    PubMed     Text format    

  13. KARLAS T, Beer S, Babel J, Busse H, et al
    Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients?
    Hepatology. 2017;65:2126-2128.
    PubMed     Text format    

  14. LING Z, Liu X, Cheng Y, Shao L, et al
    Blood microbiota as a potential noninvasive diagnostic biomarker for liver fibrosis in severely obese patients: Choose carefully.
    Hepatology. 2017;65:1775-1776.
    PubMed     Text format    

  15. MARTINEZ J, Tellez L, Albillos A
    Acute variceal bleeding in patients on primary prophylaxis with nonselective beta-blockers: A poor prognosis factor?
    Hepatology. 2017;65:1774.
    PubMed     Text format    

  16. HERNAEZ R, El-Serag H, DeBakey ME
    Hepatocellular Carcinoma Surveillance: The Road Ahead.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28983.
    PubMed     Text format    

  17. VAN ASTEN M, Verhaegh P, Koek G, Verbeek J, et al
    The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.
    Hepatology. 2016 Nov 10. doi: 10.1002/hep.28940.
    PubMed     Text format    

  18. VERLINDEN W, Francque S, Michielsen P, Vanwolleghem T, et al
    Successful antiviral treatment of chronic hepatitis C leads to a rapid decline of liver stiffness without an early effect on spleen stiffness.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28610.
    PubMed     Text format    

  19. PONZETTO A, Srinivasan RS
    Risk factors for hepatocellular carcinoma.
    Hepatology. 2016 Sep 28. doi: 10.1002/hep.28854.
    PubMed     Text format    

  20. CUSI K
    Nonalcoholic Steatohepatitis in Non-Obese Patients: Not So Different After All.
    Hepatology. 2016 Sep 20. doi: 10.1002/hep.28839.
    PubMed     Text format    

  21. THIELE M, Madsen BS, Krag A
    Is liver stiffness equal to liver fibrosis?
    Hepatology. 2017;65:749.
    PubMed     Text format    

  22. VERGANI D, Mieli-Vergani G
    Mouse model of primary biliary cholangitis with a striking female predominance: A new powerful research tool.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28718.
    PubMed     Text format    

  23. ABRALDES JG, Burak KW
    STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28537.
    PubMed     Text format    

  24. SURAWEERA D, Saab S
    Hepatitis C Treatment Threshold in Patients with Decompensated Liver Disease.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29175.
    PubMed     Text format    

    Clinical Criteria are Critical to Diagnosing Alcoholic Hepatitis.
    Hepatology. 2017 Apr 1. doi: 10.1002/hep.29188.
    PubMed     Text format    

  26. DHALIWAL A, Towey J, Haydon G, Elsharkawy AM, et al
    Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis.
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29801.
    PubMed     Text format    

  27. BERZIGOTTI A, Bosch J
    Reply to "Balancing exercise-induced weight loss with protein caloric requirement remains a challenge in overweight patients with cirrhosis".
    Hepatology. 2018 Jan 22. doi: 10.1002/hep.29799.
    PubMed     Text format    

  28. PHILIPS CA, Augustine P
    Plasma biomarkers to diagnose alcoholic hepatitis - are we there yet?
    Hepatology. 2017 Sep 23. doi: 10.1002/hep.29547.
    PubMed     Text format    

  29. WREE A, Inzaugarat ME, Feldstein AE
    Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.
    Hepatology. 2018;67:438-441.
    PubMed     Text format    

  30. SINGH S, Loomba R
    Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases.
    Hepatology. 2018;67:13-15.
    PubMed     Text format    

  31. XANTHAKOS SA, Trout AT, Dillman JR
    Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect.
    Hepatology. 2017;66:1373-1376.
    PubMed     Text format    

  32. LIU Z, Que S, Mardinoglu A
    Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients.
    Hepatology. 2017;66:1357-1358.
    PubMed     Text format    

  33. SAFIRI S, Khazaei S, Mansori K, Ayubi E, et al
    Comments on "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis".
    Hepatology. 2017;66:1358-1359.
    PubMed     Text format    

  34. HE Y, Gao B
    A small specific-sized hyaluronic acid ameliorates alcoholic liver disease by targeting a small RNA: New hope for therapy?
    Hepatology. 2017;66:321-323.
    PubMed     Text format    

  35. O'HARA SP, LaRusso NF
    Cellular Senescence, Neuropeptides and Hepatic Fibrosis: Additional Insights into Increasing Complexity.
    Hepatology. 2017 May 2. doi: 10.1002/hep.29243.
    PubMed     Text format    

  36. DELLAVANCE A, Ferraz MLG, Cancado ELR, Andrade LEC, et al
    Expansion and intensification of humoral autoimmune response in the transition from preclinical to full-blown primary biliary cholangitis.
    Hepatology. 2017;66:997.
    PubMed     Text format    

  37. WANG Z, Han J, Zhang H, Wu MC, et al
    Emphasis on Harms of Hepatocellular Carcinoma Surveillance: Just Pretending Innocent After Taking Advantages?
    Hepatology. 2017 May 24. doi: 10.1002/hep.29288.
    PubMed     Text format    

    Linking long non-coding RNA to control bile acid signaling and cholestatic liver fibrosis.
    Hepatology. 2017 May 24. doi: 10.1002/hep.29289.
    PubMed     Text format    

  39. SIMONETTO DA, Kamath PS, Shah VH
    Alcoholic Hepatitis: Continued drinking and the mourning after.
    Hepatology. 2017 Jul 3. doi: 10.1002/hep.29349.
    PubMed     Text format    

    J Gastroenterol

  40. FLOREANI A, Tanaka A, Bowlus C, Gershwin ME, et al
    Geoepidemiology and changing mortality in primary biliary cholangitis.
    J Gastroenterol. 2017 Apr 1. doi: 10.1007/s00535-017-1333.
    PubMed     Text format     Abstract available

  41. TAJIRI K, Kawai K, Sugiyama T
    Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases.
    J Gastroenterol. 2017;52:724-733.
    PubMed     Text format     Abstract available

    Lancet Glob Health

  42. LEMOINE M, Shimakawa Y, Njie R, Taal M, et al
    Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
    Lancet Glob Health. 2016;4:e559-67.
    PubMed     Text format     Abstract available

    Transplant Proc

  43. YU YD, Kim DS, Han JH, Yoon YI, et al
    Successful Treatment of a Patient With Diffuse Portosplenomesenteric Thrombosis Using a Pericholedochal Varix for Portal Flow Reconstruction During Deceased Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1202-1206.
    PubMed     Text format     Abstract available

  44. KWON HM, Jun IG, Jung KW, Moon YJ, et al
    Pretransplant Resting Heart Rate and Its Association With All-Cause Mortality in Liver Transplant Recipients.
    Transplant Proc. 2017;49:1092-1096.
    PubMed     Text format     Abstract available

  45. KIM SH, Moon YJ, Kim JW, Song JG, et al
    Prediction of Fluid Responsiveness by a Non-invasive Respiratory Systolic Time Interval Variation Using Heart Sound Signals in Recipients Undergoing Liver Transplantation.
    Transplant Proc. 2017;49:1082-1086.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.